NasdaqGS:IOSPChemicals
Innospec (IOSP) Margin Rebuild To 6.6% Renews Bullish Narrative After Prior Weakness
Innospec (IOSP) has wrapped up FY 2025 with fourth quarter revenue of US$455.6 million and basic EPS of US$1.91, alongside full year trailing EPS of US$4.69 on revenue of US$1.78 billion that reflects a very large year on year earnings pickup. Over recent quarters the company has seen revenue move from US$466.8 million in Q4 2024 to US$455.6 million in Q4 2025. Basic EPS shifted from a loss of US$2.82 to a profit of US$1.91, setting the stage for investors to focus on how the higher 6.6% net...